Unsupported browser

You are using an outdated browser. Please upgrade your browser to improve your experience.

Sign up for an Award

Participate with your entry in one of our professional or student awards.

Sign up for an award

Sign up for a Profile

Create your own profile and publish it in the iF WORLD DESIGN GUIDE.

Sign up for a profile

Learn more:

iF SOCIAL IMPACT PRIZE (free of charge)

Present your project for free and win your share of EUR 50,000 in prize money.

Publish your project

dermaject / Injection device

dermaject
dermaject

Discipline: Product

dermaject
dermaject
dermaject
dermaject
dermaject

Discipline: Product

Dermaject is a specialty drug delivery device for the injection of liquid drugs, such as therapeutic cancer treatments into the upper layer of the skin (the dermis, just below the skin surface). Most intradermal (i.d.) injections are carried out manually with painful thick needles and an error rate of about 20%. Dermaject standardizes injections, reduces errors, is 2 times faster and, thanks to a needlestick injury shield, is far less painful. Intradermal injections using dermaject exhibit up to 30x increased efficacy compared to the normal subcutaneous route. It is also the only device mimicking the Mantoux method of sharp angle entry.

  • TARGET GROUPS Trade / Industry, Specific sub-group: Pharma

  • TARGET REGIONS Asia, Australia/Oceania, Europe, North America

  • DEVELOPMENT TIME 25 - 36 months

  • DATE OF LAUNCH 2017

Client / Manufacturer

Hahn-Schickard

Hahn-Schickard
Villingen-Schwenningen, Germany

Client / Manufacturer

Verapido Medical GmbH

Verapido Medical GmbH
Villingen-Schwenningen, Germany

Go to profile
Design

Verapido Medical GmbH

Verapido Medical GmbH
Villingen-Schwenningen, Germany

Michael Kegel, Thomas Lorenz, Dr. med. Markus Clemenz

Go to profile